EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
EIDX
Delisted
EIDX was delisted on the 25th of January, 2021.
78 hedge funds and large institutions have $418M invested in Eidos Therapeutics, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 26 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
35% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 26
Holders
78
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$8.9M | |
| 2 | +$5.12M | |
| 3 | +$3.42M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$3.28M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
+$2.61M |
Top Sellers
| 1 | -$34.3M | |
| 2 | -$7.6M | |
| 3 | -$3.65M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$3.16M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$2.25M |